HillSignal

TICKER INTELLIGENCE

$GH

Company & Legislative Profile

$GH is a publicly traded company in the Healthcare sector. This company operates across Healthcare and is subject to various Congressional legislative and regulatory actions. HillSignal is tracking 1 active Congressional signal mentioning $GH, including 1 bill. The current legislative sentiment is predominantly bullish, suggesting potential tailwinds from government policy.

$GH is currently facing 1 active congressional signal tracked by HillSignal. With 1 bullish, and 0 bearish signal, the average legislative impact score is 4.0/10. Key sectors affected include Healthcare and Technology. Recent major catalysts include Reducing Hereditary Cancer Act. Below is the complete tracker of government activity affecting $GH’s market performance.

1

Total Signals

4.0/10

Avg Impact

1

Bullish Signals

0

Bearish Signals

Related Sectors

HealthcareTechnology

Recent Congressional Signals for $GH

Reducing Hereditary Cancer Act

BULLISH

The Reducing Hereditary Cancer Act (HR4752) mandates Medicare coverage for germline mutation testing—a direct expansion of the addressable market for genetic diagnostics companies. The bill is in early committee stage (referred to Energy & Commerce and Ways & Means), with a Senate companion bill (S2760) also introduced. Real market data shows genetic testing/ diagnostics tickers have declined 0.09% to 5.12% in the past week, but this bill represents structural demand expansion independent of recent price action.

Impact: 4/10HR4752Congressional Bill

Understanding These Signals

What is a Signal?Impact ScoreMarket SentimentFederal ContractsFull Glossary →

Get Full Access to $GH Signals

Daily AI-analyzed alerts for Congressional activity affecting your portfolio.

Get Started →